Carfilnat (Carfilzomib) 60mg

Carfilnat 60mg is a prescription medication used for multiple myeloma treatment. This proteasome inhibitor supports cancer therapy by targeting specific proteins. Store at 2-8°C to maintain potency. Always follow healthcare provider guidance when using this medication.

Strength

60mg

Pack Size

Storage

2-8ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carfilnat 60mg is prescribed for adults with multiple myeloma, a type of blood cancer. It works by interfering with cancer cell growth and survival. Patients often use it in combination with other therapies for better outcomes. What is Carfilnat 60mg used for in cancer treatment?

Side Effects

Carfilnat 60mg may cause fatigue, nausea, or low blood cell counts as common effects. Some users report digestive discomfort or muscle pain during therapy. These effects vary by individual and treatment stage. Always discuss persistent symptoms with a healthcare professional.

Precautions & Warnings

Keep Carfilnat 60mg refrigerated between 2-8°C to preserve its effectiveness. Protect from light and moisture during storage. Handle with care to avoid contamination. Do not use if the packaging appears damaged or discolored. Consult a pharmacist for proper handling instructions.

Avoid Interactions

Carfilnat 60mg may interact with other medications affecting blood pressure or heart rhythm. Avoid grapefruit products as they can alter drug metabolism. Inform your doctor about all prescription, over-the-counter, and herbal products you're using. Some interactions may require dose adjustments or monitoring.

Frequently Asked Questions

Carfilnat 60mg is used to treat multiple myeloma in adults, typically in combination with other cancer medications.

Store Carfilnat 60mg between 2-8°C in its original packaging, protected from light and moisture.

Consult your healthcare provider before combining Carfilnat 60mg with other drugs to avoid potential interactions.

Common effects may include fatigue, nausea, or low blood cell counts; report persistent symptoms to your doctor.

Carfilnat 60mg is a proteasome inhibitor used in cancer therapy but is not classified as traditional chemotherapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.